Kemal Erbil

784 total citations
19 papers, 638 citations indexed

About

Kemal Erbil is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Epidemiology. According to data from OpenAlex, Kemal Erbil has authored 19 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Kemal Erbil's work include Adipokines, Inflammation, and Metabolic Diseases (4 papers), Atherosclerosis and Cardiovascular Diseases (2 papers) and Hematological disorders and diagnostics (2 papers). Kemal Erbil is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (4 papers), Atherosclerosis and Cardiovascular Diseases (2 papers) and Hematological disorders and diagnostics (2 papers). Kemal Erbil collaborates with scholars based in Türkiye, United States and Serbia. Kemal Erbil's co-authors include James D. Jones, Erdinç Çakır, Alper Sönmez, Taner Özgürtaş, Mahmut İlker Yılmaz, Ömer Özcan, George G. Klee, Tayfun Eyıleten, Cengizhan Açıkel and Kayser Çağlar and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and American Journal of Kidney Diseases.

In The Last Decade

Kemal Erbil

19 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kemal Erbil Türkiye 12 187 128 123 100 93 19 638
Akanksha Gupta United States 16 137 0.7× 129 1.0× 223 1.8× 108 1.1× 94 1.0× 32 766
Asora Fux Israel 12 114 0.6× 95 0.7× 85 0.7× 55 0.6× 110 1.2× 19 530
E.S.G. Stroes Netherlands 12 113 0.6× 118 0.9× 150 1.2× 91 0.9× 191 2.1× 22 888
Zhimin Du China 14 181 1.0× 84 0.7× 133 1.1× 58 0.6× 97 1.0× 34 560
Lysette N. Broekhuizen Netherlands 9 148 0.8× 149 1.2× 76 0.6× 118 1.2× 138 1.5× 16 756
Pin‐Ming Liu China 15 164 0.9× 76 0.6× 111 0.9× 48 0.5× 113 1.2× 50 563
K. C. Siamopoulos Greece 15 91 0.5× 140 1.1× 128 1.0× 108 1.1× 125 1.3× 31 717
Dae Hyun Lee United States 14 233 1.2× 176 1.4× 193 1.6× 112 1.1× 147 1.6× 53 947
Franco Carmassi Italy 12 194 1.0× 58 0.5× 76 0.6× 63 0.6× 123 1.3× 34 739
J. Michael United Kingdom 15 67 0.4× 196 1.5× 116 0.9× 106 1.1× 76 0.8× 27 699

Countries citing papers authored by Kemal Erbil

Since Specialization
Citations

This map shows the geographic impact of Kemal Erbil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kemal Erbil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kemal Erbil more than expected).

Fields of papers citing papers by Kemal Erbil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kemal Erbil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kemal Erbil. The network helps show where Kemal Erbil may publish in the future.

Co-authorship network of co-authors of Kemal Erbil

This figure shows the co-authorship network connecting the top 25 collaborators of Kemal Erbil. A scholar is included among the top collaborators of Kemal Erbil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kemal Erbil. Kemal Erbil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Çaycı, Tuncer, Emin Özgür Akgül, Yasemin Gülcan Kurt, et al.. (2011). The levels of nitric oxide and asymmetric dimethylarginine in the rat endometriosis model. Journal of obstetrics and gynaecology research. 37(8). 1041–1047. 16 indexed citations
2.
Yaman, Halıl, Erdinç Çakır, Emin Özgür Akgül, et al.. (2011). Pentraxin 3 as a potential biomarker of acetaminophen-induced liver injury. Experimental and Toxicologic Pathology. 65(1-2). 147–151. 10 indexed citations
3.
Özgürtaş, Taner, İbrahim Aydın, Özden Turan, et al.. (2011). Soluble Vascular Endothelial Growth Factor Receptor 1 in Human Breast Milk. Hormone Research in Paediatrics. 76(1). 17–21. 7 indexed citations
4.
Çakır, Erdinç, Özgür Akgül, Tuncer Çaycı, et al.. (2010). The association between neopterin and acetaminophen-induced nephrotoxicity. Renal Failure. 32(6). 740–746. 18 indexed citations
5.
Koç, Erol, Emin Özgür Akgül, Ahmet Akar, et al.. (2009). Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open‐label study. The Journal of Dermatology. 36(4). 191–196. 5 indexed citations
6.
Öngürü, Pınar, Emin Özgür Akgül, Esragül Akıncı, et al.. (2008). High serum levels of neopterin in patients with Crimean–Congo hemorrhagic fever and its relation with mortality. Journal of Infection. 56(5). 366–370. 32 indexed citations
7.
Sönmez, Alper, Teoman Doğru, İlker Taşçı, et al.. (2006). Relationship between plasma visfatin levels and the metabolic variables in metabolic syndrome. 1 indexed citations
8.
Sönmez, Alper, Halil Genç, Mahmut Gök, et al.. (2006). The plasma levels of soluble P-selectin in subjects with prediabetes. International Journal of Clinical Practice. 60(9). 1048–1052. 11 indexed citations
9.
Sönmez, Alper, Teoman Doğru, Mahmut İlker Yılmaz, et al.. (2006). Adiponectin and Insulin Resistance in Young and Healthy Smokers. Endocrine Journal. 53(6). 729–734. 5 indexed citations
10.
İfran, Ahmet, Adnan Haşimi, Kürşat Kaptan, et al.. (2005). Evaluation of platelet parameters in healthy apheresis donors using the ADVIA 120™. Transfusion and Apheresis Science. 33(2). 87–90. 18 indexed citations
11.
Yılmaz, Mahmut İlker, Mutlu Sağlam, Kayser Çağlar, et al.. (2005). The Determinants of Endothelial Dysfunction in CKD: Oxidative Stress and Asymmetric Dimethylarginine. American Journal of Kidney Diseases. 47(1). 42–50. 267 indexed citations
12.
Sönmez, Alper, et al.. (2005). Soluble CD40 Ligand Levels in Patients with Hypertension. Clinical and Experimental Hypertension. 27(8). 629–634. 9 indexed citations
13.
Yılmaz, Mahmut İlker, Mutlu Sağlam, Kayser Çağlar, et al.. (2005). Endothelial Functions Improve with Decrease in Asymmetric Dimethylarginine (ADMA) Levels after Renal Transplantation. Transplantation. 80(12). 1660–1666. 67 indexed citations
14.
Tozkoparan, Ergün, Ömer Deniz, Ferda Çiftçi, et al.. (2005). The diagnostic values of serum, pleural fluid and urine neopterin measurements in tuberculous pleurisy.. PubMed. 9(9). 1040–5. 23 indexed citations
15.
Koçak, Gülendam, et al.. (2003). The protective effect of melatonin on adriamycin-induced acute cardiac injury.. PubMed. 19(5). 535–41. 14 indexed citations
16.
Akgül, Özgür, Ergün Tozkoparan, May Alrashed, et al.. (2003). Urinary neopterin measurement as a non-invasive diagnostic method in pulmonary tuberculosis.. PubMed. 7(8). 771–6. 18 indexed citations
17.
Çağlayan, Sinan, Metin Özata, Gökhan Özışık, et al.. (2001). Plasma Melatonin Concentration before and during Testosterone Replacement in Klinefelter’s Syndrome: Relation to Hepatic Indolamine Metabolism and Sympathoadrenal Activity. The Journal of Clinical Endocrinology & Metabolism. 86(2). 738–743. 12 indexed citations
18.
Erbil, Kemal, et al.. (1986). Significance of serum protein and lipid-bound sialic acid as a marker for genitourinary malignancies. Cancer. 57(7). 1389–1394. 35 indexed citations
19.
Erbil, Kemal, James D. Jones, & George G. Klee. (1985). Use and limitations of serum total and lipid-bound sialic acid concentrations as markers for colorectal cancer. Cancer. 55(2). 404–409. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026